Adenosine deaminase anticancer therapy
First Claim
Patent Images
1. A method of treating a patient having a tumor or cancer of the prostate or ovaries comprising administering an effective amount of adenosine deaminase to the patient in need thereof, wherein the adenosine deaminase is adenosine deaminase purified from a bovine source or is a recombinant bovine adenosine deaminase according to SEQ ID NO:
- 5 or SEQ ID NO;
1, oris a recombinant bovine adenosine deaminase according to SEQ ID NO;
1 or SEQ ID NO;
5, with an amino acid substitution selected from the group consisting of Gln in place of Lys198;
Ala in place of Thr245;
Arg in place of Gly351 and combinations thereof;
wherein the adenosine deaminase is conjugated to polyethylene glycol; and
wherein the polyethylene glycol ranges in size from about 4,000 to about 45,000 Daltons.
9 Assignments
0 Petitions
Accused Products
Abstract
What is provided is a method of treating a patient having a tumor comprising administering an effective amount of adenosine deaminase, preferably polyalkylene oxide conjugated, to a patient in need thereof.
-
Citations
19 Claims
-
1. A method of treating a patient having a tumor or cancer of the prostate or ovaries comprising administering an effective amount of adenosine deaminase to the patient in need thereof, wherein the adenosine deaminase is adenosine deaminase purified from a bovine source or is a recombinant bovine adenosine deaminase according to SEQ ID NO:
- 5 or SEQ ID NO;
1, oris a recombinant bovine adenosine deaminase according to SEQ ID NO;
1 or SEQ ID NO;
5, with an amino acid substitution selected from the group consisting of Gln in place of Lys198;
Ala in place of Thr245;
Arg in place of Gly351 and combinations thereof;wherein the adenosine deaminase is conjugated to polyethylene glycol; and
wherein the polyethylene glycol ranges in size from about 4,000 to about 45,000 Daltons. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19)
- 5 or SEQ ID NO;
Specification